Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
In case you weren’t able to make it to EuroPCR’s e-Course last week, you missed a great discussion among some of coronary IVL’s most knowledgeable operators about how they’re using the technology in the real-world setting. Lucky for you, we’ve included the sponsored roundtable discussion below featuring Drs. Benjamin Honton (FR), Javier Escaned (ES) and Michael Lee (HK). We hope you enjoy hearing their perspectives from across Europe and Asia.
Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2, Coronary Conferences
Intravascular Lithotripsy (IVL) has been used and studied across all peripheral vessels, with multiple published studies in CFA, SFA, Popliteal and Infrapopliteal arteries.
Topics: Peripheral IVL, Peripheral Clinical Data
Learn about Alternative Access Approaches and Techniques for TAVR in this case-based webcast CME certification, led by Drs. James McCabe, Ole De Backer, Chandan Devireddy, and Pradeep Yadav.
Topics: Peripheral IVL
Acute recoil is a phenomenon in small arteries, such as those below-the-knee (BTK), when there is a significant reduction in luminal gain within just a few minutes after balloon angioplasty. Since the goal of BTK angioplasty is to maximize distal flow in order to heal wounds, recoil is a significant problem. As a result, reducing the incidence of acute recoil should be an important goal in improving BTK treatment.
Topics: Peripheral IVL, Peripheral Clinical Data, Shockwave S4
Recently, Dr. James Spratt, consultant cardiologist at St George's University NHS Trust in London and founder of Optima Education, and other leading UK cardiologists published their experience with Intravascular Lithotripsy (IVL) in the left main in EuroIntervention: Intravascular lithotripsy for the treatment of calcific distal left main disease.
Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2
The story of how Intravascular Lithotripsy (IVL) came into being is a paragon of true innovation – it could be a chapter out of Steven Johnson’s book, Where Good Ideas Come From. The founders demonstrate a textbook example of how the amalgamation of building liquid networks, developing the slow hunch, error, serendipity, and expanding into the adjacent possible led to the disruptive innovation that is IVL.
See what role a child’s piece of chalk, organic chicken eggs and cadaver legs all play in IVL’s journey from idea to reality in this fun video.
Topics: IVL Technology, SWAV News
At Shockwave, we’re committed to the creation of sound clinical evidence to support the adoption and long-term utilization of our technology. This includes a balance of high-quality Shockwave-sponsored and investigator-initiated research studies to advance the knowledge of our technology’s performance in daily practice.
While you can read more about our company-sponsored clinical trials on the website here, there hasn’t been a good resource for our customers to understand what investigator-initiated studies we’re also supporting…until now.
Topics: Coronary Clinical Data, Shockwave C2
Last month, we had the pleasure of being hosted by Prof. Holger Nef from Giessen, Germany, and Dr. Nikos Werner at his cath lab in Trier, Germany, for a day of cases followed by a live webinar with InCathLab.
Topics: Coronary IVL, Shockwave C2
This case was the winner of the inaugural TopShock case competition at TCT 2019 – a satellite symposium sponsored by Shockwave Medical. This post was written by Dr. Thomas E. Waggoner for The Catalyst.
Topics: Peripheral IVL, Peripheral Conferences
Recently, Dr. Stefan Harb partnered with Drs. Patrick Siegrist and Tim Schäufele to host the first ever IVL workshop in the DACH region at LKH Graz II Standort West in Graz, Austria. We asked Stefan to relay some of his key takeaways during the workshop and some of the more interesting discussions for the benefit of IVL users across the EU. We hope you enjoy his recap:
Topics: Coronary IVL, IVL Technology, Shockwave C2
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
